Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab

NCT00776763 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ophthalmological Association Edelweiss

Collaborators